Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06897280 · ClinicalTrials.gov registry record · Phase 4
Clinical Trial of MED HF10™ Spinal Cord Stimulation for the Treatment of Chronic Pain
A Phase 4 study of Chronic, Intractable Back Pain And/or Leg Pain, sponsored by Nevro.
- Active
- Registry status
- Phase 4
- Development phase
- 25
- Enrollment target
- 1
- Study location
NCT06897280 is a Phase 4 study of Chronic, Intractable Back Pain And/or Leg Pain that is active but no longer recruiting, run by Nevro. The registered enrollment target is 25 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06897280, a Phase 4 study of Chronic, Intractable Back Pain And/or Leg Pain, is active but no longer recruiting, sponsored by Nevro.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 4
- Development phase
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a single-center, prospective, non-randomized exploratory study in subjects with chronic, intractable back pain and/or leg pain per the center's routine practice. The primary endpoint is the distribution of responders by 'lowest preferred pulse dose (PD)' setting, where a subject is a responder to the lowest PD setting they preferred prior to entering the Observational period. The study is performed in patients who already have Nevro SCS devices implanted.
Conditions Studied
Interventions
- DEVICE SCS Device Program Setting
Study Locations (1)
Kansas
- Neuroscience Research Center - Overland Park
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2021-11-16 |
| Est. Completion | 2026-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06897280
The ClinicalTrials.gov registry entry for NCT06897280 describes a study currently listed as active not recruiting, categorized as Phase 4. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Nevro, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Chronic, Intractable Back Pain And/or Leg Pain appearing as the primary indexed condition, and to 1 intervention - of which SCS Device Program Setting is the first listed.
NCT06897280 reports 1 study location spanning 1 distinct geographic area - top geographies include Kansas.
Frequently Asked Questions
What is clinical trial NCT06897280 about?
NCT06897280 is a clinical study titled "Clinical Trial of MED HF10™ Spinal Cord Stimulation for the Treatment of Chronic Pain". This is a single-center, prospective, non-randomized exploratory study in subjects with chronic, intractable back pain and/or leg pain per the center's routine practice. The primary endpoint is the distribution of responders by 'lowest preferred pulse dose (PD)' setting, where a subject is a respond...
What is the current status of trial NCT06897280?
This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 25 participants. The study started on 2021-11-16. Estimated completion is 2026-12.
What conditions does trial NCT06897280 study?
This clinical trial studies the following conditions: Chronic, Intractable Back Pain And/or Leg Pain.
What interventions are being tested in trial NCT06897280?
The interventions under investigation include: SCS Device Program Setting (DEVICE).
Who is sponsoring clinical trial NCT06897280?
This trial is sponsored by Nevro, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06897280 being conducted?
This trial has 1 study location across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.